<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>tek hücreli transkriptomik &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tek-hucreli-transkriptomik/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 22 Nov 2025 06:55:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>tek hücreli transkriptomik &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Lactylation Marks Tumor Clusters, Predicts Glioblastoma Outcome</title>
		<link>https://bioengineer.org/lactylation-marks-tumor-clusters-predicts-glioblastoma-outcome/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 22 Nov 2025 06:54:56 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[İşte 5 adet uygun etiket: **glioblastoma laktilasyonu]]></category>
		<category><![CDATA[metabolik epigenetik** **Açıklama:** 1. **glioblastoma laktilasyonu:** Doğrudan makalenin ana konusunu (laktilasyonun GBM'deki rolü)]]></category>
		<category><![CDATA[prognostik belirteçler]]></category>
		<category><![CDATA[tek hücreli transkriptomik]]></category>
		<category><![CDATA[tümör heterojenitesi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/lactylation-marks-tumor-clusters-predicts-glioblastoma-outcome/</guid>

					<description><![CDATA[Glioblastoma (GBM) stands out as the most malignant and aggressive form of adult brain cancer, notorious for its remarkable intratumoral heterogeneity and resistance to conventional therapies. Despite ongoing advancements in neuro-oncology, the prognosis for GBM patients remains grim, with survival rates stubbornly low. A groundbreaking study published in BMC Cancer in 2025 has illuminated a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">299882</post-id>	</item>
	</channel>
</rss>
